In bladder cancer, circTCF25 downregulates miR-103a-3p and miR-107 as well as upregulates cyclin-dependent kinases 6 (CDK6), suggesting that circTCF25 is a new biomarker (Zhong, Lv & Chen, 2016). This evidence concerns the gene CDK6 and urinary bladder carcinoma.